Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
55.17
-1.69 (-2.96%)
At close: Sep 15, 2026, 4:00 PM EDT
55.89
+0.73 (1.31%)
After-hours: Sep 15, 2026, 7:53 PM EDT

Spruce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
159931711926105
Market Cap Growth
2170.86%437.50%-85.46%361.35%-75.29%-81.46%
Enterprise Value
7084-3916-5819
Last Close Price
56.8587.1131.50219.7582.31334.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.5311.82--
PB Ratio
1.872.190.601.560.380.94
P/TBV Ratio
1.892.190.601.560.380.94

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---1.62--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.090.020.100.060.090.06
Net Debt / Equity Ratio
-1.06-1.13-1.25-1.20-1.06-0.74
Net Debt / EBITDA Ratio
2.271.690.641.771.541.96
Net Debt / FCF Ratio
2.071.450.642.761.752.29
Asset Turnover
--0.070.11--
Quick Ratio
8.785.112.543.946.3510.03
Current Ratio
9.235.172.904.186.7210.36
Return on Equity (ROE)
-105.98%-109.24%-100.70%-66.10%-51.35%-32.43%
Return on Assets (ROA)
-40.03%-36.41%-47.06%-34.28%-27.86%-18.17%
Return on Capital Employed (ROCE)
-43.50%-66.60%-187.40%-65.40%-64.60%-35.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-32.49%-41.79%-305.73%-40.17%-178.61%-40.41%
FCF Yield
-27.06%-35.74%-322.61%-27.90%-161.25%-34.37%
Buyback Yield / Dilution
-149.78%-39.34%-7.14%-63.68%-0.71%-289.93%